Email Updates

You are here

Webinar & Meeting Reports

  • July 23, 2013

    The sixth webinar in our series addressing a range of topics in HIV prevention research, hosted jointly by NAM and AVAC, will focus on the next generation of male and female condoms being introduced to meet specific HIV prevention needs.

  • June 30, 2013 to July 3, 2013

    Held every two years, the IAS Conference on HIV Pathogenesis, Treatment and Prevention includes many sessions on a range of HIV-related topics. Approximately 4,000 scientists, community leaders, public health experts and advocates met between June 30-July 3 in the Kuala Lumpur Convention Center.

  • June 18, 2013

    AVAC and the Harm Reduction Coalition organized a teleconference to discuss the recent results of the Bangkok Tenofovir Study, a Thai trial of pre-exposure prophylaxis in injecting drug users.

  • June 18, 2013 to June 21, 2013

    SA AIDS is a biannual meeting, serving as the primary opportunity to discuss progress and success—as well as challenges—in addressing the country’s epidemic. This year’s conference theme was Building on Successes: Integrating Systems. The conference hoped to provide a critical venue to discuss the status of biomedical research, as well as the progress of moving key interventions such as treatment as prevention and voluntary medical male circumcision to wider scale implementation.

  • June 11, 2013

    The fifth webinar in a series addressing a range of topics in HIV prevention research, hosted jointly by NAM and AVAC. This installment looked at recent developments and future directions in the area of cure research. To view the full Flash animation of the webinar, click here.

  • June 11, 2013

    This AVAC global advocates' webinar was on the topic of voluntary medical male circumcision (VMMC) devices and the recent news that the World Health Organization had prequalified the PrePex device. The goal of the webinar was to help advocates understand the prequalification process, recent events and discuss next steps for rollout. There was a brief presentation followed by a moderated discussion.

  • May 27, 2013 to May 30, 2013

    Over 7,000 participants from around the world, including government leaders, policy makers, healthcare professionals, NGO representatives, corporate leaders and global media outlets met in Kuala Lumpur for Women Deliver 2013 (WD2013) .

  • May 18, 2013

    AVAC is excited to be working with civil society and research partners across the globe on a number of community events to commemorate HIV Vaccine Awareness Day.

  • May 9, 2013

    The fourth webinar in our series addressed a range of topics in HIV prevention research, hosted jointly by NAM and AVAC, and looked at the current situation regarding pre-exposure prophylaxis (PrEP) in Europe and the US. Presenters discussed the ongoing IPERGAY study in France and the PROUD study in England, and reviewed progress in the NEXT-PrEP and demonstration studies in the US.

  • April 30, 2013

    The US National Institute of Allergy and Infectious Diseases (NIAID) and HIV Vaccine Trials Network (HVTN) accounced that the HVTN 505 AIDS vaccine clinical trial would cease immunizations early after the independent Data and Safety Monitoring Board (DSMB) determined during a scheduled interim review that the vaccine regimen being tested is not effective.